Mycobacterium avium subsp. Paratuberculosis (MAP) as a modifying factor in Crohn's disease

Inflammatory Bowel Diseases

Volumn 16, Issue 2, 2010, Pages 296-304

  Sibartie, Shomik ^a   Scully, Paul ^a   Keohane, John ^a   O'Neill, Shaun ^a   O'Mahony, Jim ^a   O'Hanlon, Deirdre ^b   Kirwan, William O ^c   O'Mahony, Liam ^a,d   Shanahan, Fergus ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b SOUTH INFIRMARY VICTORIA UNIVERSITY HOSPITAL   (Ireland)

^c University College Cork and INFANT Centre   (Ireland)

^d SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

Author keywords

Crohn's disease; Cytokine; Inflammatory bowel disease; Mycobacterium; Paratuberculosis

Indexed keywords

CYTOKINE;

ADULT; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; INFLAMMATORY DISEASE; LISTERIA MONOCYTOGENES; MALE; MESENTERY LYMPH NODE; MYCOBACTERIUM AVIUM; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; T LYMPHOCYTE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROHN DISEASE; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; PARATUBERCULOSIS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 73949103757     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21052     Document Type: Article

References (41)

1. Gould G, Franken P, Hammer P, et al. Mycobacterium avium subsp. paratuberculosis (MAP) and the food chain. Food Protection Trends. 2005;25:268-297.
2. Grant IR. Zoonotic potential of Mycobacterium avium ssp. paratuberculosis: the current position. J Appl Microbiol. 2005;98:1282-1293.
3. Uzoigwe JC, Khaitsa ML, Gibbs PS. Epidemiological evidence for Mycobacterium avium subspecies paratuberculosis as a cause of Crohn's disease. Epidemiol Infect. 2007;135:1057-1068.
4. Waddell LA, Rajić A, Sargeant J, et al. The zoonotic potential of Mycobacterium avium spp. paratuberculosis: a systematic review. Can J Public Health. 2008;99:145-155.
5. Feller M, Huwiler K, Stephan R, et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis. 2007;7:607-613.
6. Abubakar I, Myhill D, Aliyu SH, et al. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm Bowel Dis. 2008;14:401-410.
7. Behr MA, Kapur V. The evidence for Mycobacterium paratuberculosis in Crohn's disease. Curr Opin Gastroenterol. 2008;24:17-21.
8. Shanahan F, O'Mahony J. The mycobacteria story in Crohn's disease. Am J Gastroenterol. 2005;100:1537-1538.
9. Rhodes JM. The role of Escherichia coli in inflammatory bowel disease. Gut. 2007;56:610-612.
10. Subramanian S, Campbell BJ, Rhodes JM. Bacteria in the pathogenesis of inflammatory bowel disease. Curr Opin Infect Dis. 2006;19:475-484.
11. Bernstein CN, Wang MH, Sargent M, et al. Testing the interaction between NOD-2 status and serological response to Mycobacterium paratuberculosis in cases of inflammatory bowel disease. J Clin Microbiol. 2007;45:968-971.
12. Bernstein CN, Blanchard JF, Rawsthorne P, et al. Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease and ulcerative colitis. J Clin Microbiol. 2004;42:1129-1135.
13. Collins MT, Lisby G, Moser C, et al. Results of multiple diagnostic tests for Mycobacterium avium subsp. paratuberculosis in patients with inflammatory bowel disease and in controls. J Clin Microbiol. 2000;38:4373-4381.
14. Barta Z, Csipo I, Mekkel G, et al. Seroprevalence of Mycobacterium paratuberculosis in patients with Crohn's disease. J Clin Microbiol. 2004;42:5432-5433.
15. Duck LW, Walter MR, Novak J, et al. Isolation of flagellated bacteria implicated in Crohn's disease. Inflamm Bowel Dis. 2007;13:1191-1201.
16. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007;117:514-521.
17. Devlin SM, Yang H, Ippoliti A, et al. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. Gastroenterology. 2007;132:576-586.
18. Packey CD, Sartor RB. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med. 2008;263:597-606.
19. Macpherson A, Khoo UY, Forgacs I, et al. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut. 1996;38:365-375.
20. O'Mahony L, O'Callaghan L, McCarthy J, et al. Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans. Am J Physiol Gastrointest Liver Physiol. 2006;290:G839-845.
21. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;26;448:427-434.
22. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;12;369:1627-1640.
23. Marks DJ, Harbord MW, MacAllister R, et al. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet. 2006;25:367:668-678.
24. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577-594.
25. Ferwerda G, Kullberg BJ, de Jong DJ, et al. Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2. J Leukoc Biol. 2007;82:1011-1018.
26. Gerold G, Zychlinsky A, de Diego JL. What is the role of Toll-like receptors in bacterial infections?Semin Immunol. 2007;19:41-47.
27. Texereau J, Chiche JD, Taylor W, et al. The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Infect Dis. 2005;419:S408-415.
28. Clancy R, Ren Z, Turton J, et al. Molecular evidence for Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease correlates with enhanced TNF-alpha secretion. Dig Liver Dis. 2007;39:445-451.
29. Weiss DJ, Evanson OA, de Souza C, et al. A critical role of interleukin-10 in the response of bovine macrophages to infection by Mycobacterium avium subsp paratuberculosis. Am J Vet Res. 2005;66:721-726.
30. Parronchi P, Romagnani P, Annunziato F, et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am J Pathol. 1997;150:823-832.
31. Fuss IJ, Neurath M, Boirivant M, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 1996;157:1261-1270.
32. Holland N, Dong J, Garnett E, et al. Reduced intracellular T-helper 1 interferon-gamma in blood of newly diagnosed children with Crohn's disease and age-related changes in Th1/Th2 cytokine profiles. Pediatr Res. 2008;63:257-262.
33. Ren Z, Turton J, Borody T, et al. Selective Th2 pattern of cytokine secretion in Mycobacterium avium subsp. paratuberculosis infected Crohn's disease. J Gastroenterol Hepatol. 2008;23:310-314.
34. Dotan I, Allez M, Nakazawa A, et al. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma. Am J Physiol Gastrointest Liver Physiol. 2007;292:G1630-1640.
35. O'Sullivan GC, Corbett AR, Shanahan F, et al. Regional immunosuppression in esophageal squamous cancer: evidence from functional studies with matched lymph nodes. J Immunol. 1996;157:4717-4720.
36. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439-444.
37. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989;298:82-86.
38. Mpofu CM, Campbell BJ, Subramanian S, et al. Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease. Gastroenterology. 2007;133:1487-1498.
39. Peeters M, Joossens S, Vermeire S, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001;96:730-734.
40. Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42:788-791.
41. Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest. 2007;131:1898-1906.